20-Jan-2026 3:00 PM CST - Business Wire Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the Vertex Pharmaceuticals Fourth Quarter 2025 Earnings Call. The conference call will be webcast live and a lin
11-Jan-2026 4:00 PM CST - Business Wire Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor meetings in January, including the companys scheduled webcast from the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 5:15 p.m. ET/2:15 p.m. PT. 2025 was a year of strong commercial execution and rapid R&D progress, setting up the company for continued growth and many important milestones in 2026, said Reshma Ke
9-Jan-2026 2:11 PM CST - Yahoo Finance UK Does Vertex Pharmaceuticals (VRTX) Share Price Reflect Its Long Term Growth Potential? If you are wondering whether Vertex Pharmaceuticals' current share price reflects its long term potential, a useful starting point is to understand how the market is valuing its future cash flows and growth prospects.
6-Jan-2026 2:06 PM CST - Yahoo Finance Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 3.8% in the afternoon session after Wolfe Research upgraded the stock from "Peer Perform" to "Outperform" and issued a $548 price target. The analyst firm pointed to a changing outlook ...
Latest VRTX Trades by Congress Members
7-AUG-2025 - David J. Taylor, OH (District 2) purchased between $1,001 and $15,000.
20-Jan-2026 3:00 PM CST - Business Wire Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the Vertex Pharmaceuticals Fourth Quarter 2025 Earnings Call. The conference call will be webcast live and a lin
11-Jan-2026 4:00 PM CST - Business Wire Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor meetings in January, including the companys scheduled webcast from the 44th annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 5:15 p.m. ET/2:15 p.m. PT. 2025 was a year of strong commercial execution and rapid R&D progress, setting up the company for continued growth and many important milestones in 2026, said Reshma Ke
9-Jan-2026 2:11 PM CST - Yahoo Finance UK Does Vertex Pharmaceuticals (VRTX) Share Price Reflect Its Long Term Growth Potential? If you are wondering whether Vertex Pharmaceuticals' current share price reflects its long term potential, a useful starting point is to understand how the market is valuing its future cash flows and growth prospects.
6-Jan-2026 2:06 PM CST - Yahoo Finance Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why Shares of biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) jumped 3.8% in the afternoon session after Wolfe Research upgraded the stock from "Peer Perform" to "Outperform" and issued a $548 price target. The analyst firm pointed to a changing outlook ...
